Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors

Lopci, E., Aide, N., Dimitrakopoulou-Strauss, A., Dercle, L., Iravani, A., Seban, R. D., Sachpekidis, C., Humbert, O., Gheysens, O., Glaudemans, A. W. J. M., Weber, W. A., Van den Abbeele, A. D., Wahl, R. L., Scott, A. M., Pandit-Taskar, N., & Hicks, R. J. (2022). Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer Imaging, 22(1). https://doi.org/10.1186/s40644-022-00512-z
Authors:
E Lopci
N Aide
A Dimitrakopoulou-Strauss
L Dercle
A Iravani
R D Seban
C Sachpekidis
O Humbert
O Gheysens
A W J M Glaudemans
W A Weber
A D Van den Abbeele
R L Wahl
A M Scott
N Pandit-Taskar
R J Hicks
Affiliated Authors:
L Dercle
Columbia Affiliation:
Subjects:
Positron Emission Tomography Computed Tomography (MeSH)
Neoplasms (MeSH)
Author Keywords:
guideline
immunotherapy
malignant tumors, precision medicine
pet/ct
positron emission tomography
treatment response
[18f]fdg
elink
Publication Type:
Article
Unique ID:
10.1186/s40644-022-00512-z
PMID:
36539908
DOI:
10.1186/s40644-022-00512-z
Journal:
Cancer Imaging
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: